NEW EMBO MEMBER'S REVIEW: Molecular background of progressive myoclonus epilepsy
Open Access
- 15 July 2003
- journal article
- review article
- Published by Springer Nature in The EMBO Journal
- Vol. 22 (14) , 3473-3478
- https://doi.org/10.1093/emboj/cdg338
Abstract
Research on human inherited diseases provides a powerful tool to identify an intrinsically important subset of genes vital to healthy functioning of the organism. Progressive myoclonus epilepsies (PMEs) are a group of rare inherited disorders characterized by the association of epilepsy, myoclonus and progressive neurological deterioration. Significant progress has been made in elucidating the molecular background of PMEs. Here, progress towards understanding the molecular pathogenesis of PMEs is reviewed using the most common single cause of PME, Unverricht–Lundborg disease, as an example. Mutations in the gene encoding cystatin B (CSTB), a cysteine protease inhibitor, are responsible for the primary defect in Unverricht–Lundborg disease. CSTB‐deficient mice, produced by targeted disruption of the mouse Cstb gene, display a phenotype similar to the human disease, with progressive ataxia and myoclonic seizures. The mice show neuronal atrophy, apoptosis and gliosis as well as increased expression of apoptosis and glial activation genes. Although significant advances towards understanding the molecular basis of Unverricht–Lundborg disease have been achieved, the physiological function of CSTB and the molecular pathogenesis of the disease remain unknown.Keywords
This publication has 65 references indexed in Scilit:
- The Gene Mutated in Variant Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN6) and in nclf Mutant Mice Encodes a Novel Predicted Transmembrane ProteinAmerican Journal of Human Genetics, 2002
- Mutations in a Novel CLN6-Encoded Transmembrane Protein Cause Variant Neuronal Ceroid Lipofuscinosis in Man and MouseAmerican Journal of Human Genetics, 2002
- The cystatins: Protein inhibitors of cysteine proteinasesPublished by Wiley ,2001
- A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2)Human Molecular Genetics, 1999
- A PCR Amplification Method Reveals Instability of the Dodecamer Repeat in Progressive Myoclonus Epilepsy (EPM1) and No Correlation between the Size of the Repeat and Age at OnsetAmerican Journal of Human Genetics, 1998
- Differences in specificity for the interactions of stefins A, B and D with cysteine proteinasesFEBS Letters, 1996
- Classification of progressive myoclonus epilepsies and related disordersAnnals of Neurology, 1990
- Cloning a synthetic gene for human stefin B and its expression in E. coliFEBS Letters, 1988
- Progressive Myoclonus Epilepsies: Specific Causes and DiagnosisNew England Journal of Medicine, 1986
- Amino acid sequence of the intracellular cysteine proteinase inhibitor cystatin B from human liverBiochemical and Biophysical Research Communications, 1985